| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0169-409X(98)00039-8 |
| P698 | PubMed publication ID | 10837677 |
| P2093 | author name string | Leroux J | |
| Gurny R | |||
| Allémann E | |||
| P433 | issue | 2-3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanotechnology | Q11468 |
| P304 | page(s) | 171-189 | |
| P577 | publication date | 1998-12-01 | |
| P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
| P1476 | title | Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics | |
| P478 | volume | 34 |
| Q26744366 | A Review of the Latest Advances in Encrypted Bioactive Peptides from Protein-Rich Waste |
| Q38911933 | A review of semi-synthetic biopolymer complexes: modified polysaccharide nano-carriers for enhancement of oral drug bioavailability |
| Q42040493 | An Approach to the Design of a Particulate System for Oral Protein Delivery .II. Preparation and Stability Study of rhGH-Loaded Microspheres in Simulated Gastrointestinal Fluids |
| Q73070860 | Anionic PAMAM dendrimers rapidly cross adult rat intestine in vitro: a potential oral delivery system? |
| Q37176392 | Antibacterial nanomedicine. |
| Q44444268 | Archaeosomes with encapsulated antigens for oral vaccine delivery |
| Q36920450 | Chitosan nanoparticles for oral drug and gene delivery |
| Q47960748 | Co-encapsulation of human serum albumin and superparamagnetic iron oxide in PLGA nanoparticles: part II. Effect of process variables on protein model drug encapsulation efficiency |
| Q46788910 | Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy |
| Q35547194 | Development of enteric submicron particle formulation of papain for oral delivery |
| Q34003731 | Development of enteric submicron particles formulation of α-amylase for oral delivery |
| Q41903629 | Development of pH-sensitive insulin nanoparticles using Eudragit L100-55 and chitosan with different molecular weights. |
| Q42129013 | Effect of the moist-heat sterilization on fabricated nanoscale solid lipid particles containing rasagiline mesylate |
| Q28579814 | Effects of indomethacin-loaded nanocapsules in experimental models of inflammation in rats |
| Q37328673 | Engineering strategies to enhance nanoparticle-mediated oral delivery. |
| Q41782073 | Formulation and evaluation of niosomes |
| Q35646236 | Formulation and optimization of mucoadhesive nanodrug delivery system of acyclovir |
| Q39369529 | Formulation, characterization and permeability study of nano particles of lipo-endomorphin-1 for oral delivery. |
| Q39785552 | Galactosylated albumin nanoparticles of simvastatin |
| Q89820673 | Heme-Derived Metabolic Signals Dictate Immune Responses |
| Q41557477 | Innovative formulation of nystatin particulate systems in toothpaste for candidiasis treatment |
| Q37358092 | Methods for the preparation and manufacture of polymeric nanoparticles. |
| Q41987261 | Microencapsulation of hemoglobin in chitosan-coated alginate microspheres prepared by emulsification/internal gelation |
| Q38543395 | Modification of drug delivery to improve antibiotic targeting to the stomach. |
| Q57345960 | Mucoadhesive drug carriers and polymers for effective drug delivery |
| Q37153923 | Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues |
| Q37948968 | Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art |
| Q37039026 | Nanoparticle strategies for the oral delivery of insulin. |
| Q37835203 | Nanoparticles in biological systems |
| Q30844270 | Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation. |
| Q28077047 | Nanotechnology: A Valuable Strategy to Improve Bacteriocin Formulations |
| Q43791013 | Novel nanoparticles for pulmonary drug administration |
| Q50891271 | Novel polyelectrolyte complexes based on poly(methacrylic acid)-bis(2-aminopropyl)poly(ethylene glycol) for oral protein delivery. |
| Q33747985 | Opioid Addiction: Social Problems Associated and Implications of Both Current and Possible Future Treatments, including Polymeric Therapeutics for Giving Up the Habit of Opioid Consumption. |
| Q36917923 | Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems. |
| Q36316646 | Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery. |
| Q31037255 | Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™. |
| Q38268308 | Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer |
| Q45105442 | Pluronic block copolymers and Pluronic poly(acrylic acid) microgels in oral delivery of megestrol acetate. |
| Q38645362 | Polymer-based vehicles for therapeutic peptide delivery |
| Q57340447 | Polymeric Drug Delivery Systems for Encapsulating Hydrophobic Drugs |
| Q39841366 | Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization |
| Q37002665 | Polymeric particulates to improve oral bioavailability of peptide drugs |
| Q38994544 | Positive Charge of "Sticky" Peptides and Proteins Impedes Release From Negatively Charged PLGA Matrices. |
| Q46600996 | Praziquantel-loaded PLGA nanoparticles: preparation and characterization |
| Q51036862 | Preparation of sub-100-nm beta-lactoglobulin (BLG) nanoparticles. |
| Q38266101 | Proteins and peptides: The need to improve them as promising therapeutics for ulcerative colitis. |
| Q34733812 | Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents |
| Q42256432 | Rivastigmine-loaded L-lactide-depsipeptide polymeric nanoparticles: decisive formulation variable optimization. |
| Q41674798 | Role of nanoparticle size, shape and surface chemistry in oral drug delivery |
| Q30855198 | Smart Microparticles with a pH-responsive Macropore for Targeted Oral Drug Delivery |
| Q36015388 | Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis |
| Q57370448 | Surfactant-Modified Poly(acrylamide-co-acrylamido propane sulphonic acid) Hydrogels |
| Q91937886 | Therapeutic efficacy of nanoparticles and routes of administration |
Search more.